The TGA has approved the expanded use of Lilly's MOUNJARO (tirzepatide) to include moderate-to-severe obstructive sleep apnoea in adults with obesity. …
TGA approves Lilly's GLP-1/GIP receptor for obstructive sleep apnoea
June 3, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Clarity announces positive top-line results from DISCO trial
June 5, 2025 - - Australian Biotech -
Clinical trial success kicks off $5m fund-raising round for WA’s Lixa
June 5, 2025 - - Australian Biotech -
Wesfarmers Health acquires Pharmacy 4 Less group
June 4, 2025 - - Latest News -
Cannabis Council Australia appoints CEO to lead next phase of industry reform
June 4, 2025 - - Latest News -
AusBiotech and Austrade launch partnership to accelerate global expansion of life sciences industry
June 4, 2025 - - Latest News -
Jordan Steele-John reappointed to represent Greens in health portfolio
June 4, 2025 - - Latest News -
Arrotex launches newly developed treatment for Australians with common skin conditions on the PBS
June 3, 2025 - - Latest News